{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:44Z","timestamp":1790139404948,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00987-x","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T02:07:50Z","timestamp":1673057270000},"page":"2773-2788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The effects of probiotics on gastrointestinal symptoms and microbiota in patients with celiac disease: a systematic review and meta-analysis on clinical trials"],"prefix":"10.1007","volume":"23","author":[{"given":"Mohammadhossein","family":"Mozafarybazargany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadian","family":"Khonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leily","family":"Sokoty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-4915","authenticated-orcid":false,"given":"Hanieh-Sadat","family":"Ejtahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and\u00a0meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823-836.e822. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.037.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.autrev.2008.05.006","volume":"7","author":"C Briani","year":"2008","unstructured":"Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev. 2008;7:644\u201350. https:\/\/doi.org\/10.1016\/j.autrev.2008.05.006.","journal-title":"Autoimmun Rev"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4291\/wjgp.v8.i2.27","volume":"8","author":"I Parzanese","year":"2017","unstructured":"Parzanese I, Qehajaj D, Patrinicola F, et al. Celiac disease: from pathophysiology to treatment. World J Gastrointest Pathophysiol. 2017;8:27\u201338. https:\/\/doi.org\/10.4291\/wjgp.v8.i2.27.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"987_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122452","author":"O Palmieri","year":"2022","unstructured":"Palmieri O, Castellana S, Bevilacqua A, et al. Adherence to gluten-free diet restores alpha diversity in celiac people but the microbiome composition is different to healthy people. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14122452.","journal-title":"Nutrients"},{"key":"987_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111817","author":"P Wi\u0119ch","year":"2018","unstructured":"Wi\u0119ch P, Chmiel Z, Bazali\u0144ski D, et al. The relationship between body composition and a gluten free diet in children with celiac disease. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10111817.","journal-title":"Nutrients"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/17474124.2020.1745630","volume":"14","author":"R Francavilla","year":"2020","unstructured":"Francavilla R, Cristofori F, Vacca M, Barone M, De Angelis M. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease. Expert Rev Gastroenterol Hepatol. 2020;14:323\u201333. https:\/\/doi.org\/10.1080\/17474124.2020.1745630.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"987_CR7","doi-asserted-by":"crossref","unstructured":"Jedwab CF, Roston BCDMB, Toge ABFDS et al. The role of probiotics in the immune response and intestinal microbiota of children with celiac disease: a systematic review. Rev Paul Pediatr. 2021;40.","DOI":"10.1590\/1984-0462\/2022\/40\/2020447"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1515\/cclm-2019-0657","volume":"58","author":"L Sacchetti","year":"2020","unstructured":"Sacchetti L, Nardelli C. Gut microbiome investigation in celiac disease: from methods to its pathogenetic role. Clin Chem Lab Med CCLM. 2020;58:340\u20139. https:\/\/doi.org\/10.1515\/cclm-2019-0657.","journal-title":"Clin Chem Lab Med CCLM"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3389\/fimmu.2020.00957","volume":"11","author":"F Pecora","year":"2020","unstructured":"Pecora F, Persico F, Gismondi P, et al. Gut microbiota in celiac disease: is there any role for probiotics? Front Immunol. 2020;11:957.","journal-title":"Front Immunol"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-10-63","volume":"10","author":"G De Palma","year":"2010","unstructured":"De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:1\u20137.","journal-title":"BMC Microbiol"},{"key":"987_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/app11178185","author":"M Conte","year":"2021","unstructured":"Conte M, Porpora M, Nigro F, et al. Pro-pre and postbiotic in celiac disease. Appl Sci. 2021. https:\/\/doi.org\/10.3390\/app11178185.","journal-title":"Appl Sci"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2249.2008.03635.x","volume":"152","author":"K Lindfors","year":"2008","unstructured":"Lindfors K, Blomqvist T, Juuti-Uusitalo K, et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 2008;152:552\u20138.","journal-title":"Clin Exp Immunol"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.14309\/ajg.0000000000000749","volume":"115","author":"CL Seiler","year":"2020","unstructured":"Seiler CL, Kiflen M, Stefanolo JP, et al. Probiotics for celiac disease: a systematic review and meta-analysis of randomized controlled trials. Off J Am Coll Gastroenterol ACG. 2020;115:1584\u201395.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"987_CR15","doi-asserted-by":"crossref","unstructured":"Harnett J, Myers S P, Rolfe M. Probiotics and the microbiome in celiac disease: a randomised controlled trial. Evid Based Complement Altern Med 2016. 2016.","DOI":"10.1155\/2016\/9048574"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/MCG.0000000000000687","volume":"51","author":"MI Pinto-S\u00e1nchez","year":"2017","unstructured":"Pinto-S\u00e1nchez MI, Smecuol EC, Temprano MP, et al. Bifidobacterium infantis NLS super strain reduces the expression of \u03b1-defensin-5, a marker of innate immunity, in the mucosa of active celiac disease patients. J Clin Gastroenterol. 2017;51:814\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1017\/S0007114514000609","volume":"112","author":"M Olivares","year":"2014","unstructured":"Olivares M, Castillejo G, Varea V, Sanz Y. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br J Nutr. 2014;112:30\u201340.","journal-title":"Br J Nutr"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.clnu.2018.06.931","volume":"38","author":"M Primec","year":"2019","unstructured":"Primec M, Klemenak M, Di Gioia D, et al. Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-\u03b1 and short-chain fatty acids. Clin Nutr. 2019;38:1373\u201381.","journal-title":"Clin Nutr"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/nu8100660","volume":"8","author":"A Quagliariello","year":"2016","unstructured":"Quagliariello A, Aloisio I, Bozzi Cionci N, et al. Effect of Bifidobacterium breve on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study. Nutrients. 2016;8:660.","journal-title":"Nutrients"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MCG.0b013e31827759ac","volume":"47","author":"E Smecuol","year":"2013","unstructured":"Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol. 2013;47:139\u201347.","journal-title":"J Clin Gastroenterol"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3920\/BM2020.0016","volume":"11","author":"E Smecuol","year":"2020","unstructured":"Smecuol E, Constante M, Temprano MP, et al. Effect of Bifidobacterium infantis NLS super strain in symptomatic coeliac disease patients on long-term gluten-free diet\u2013an exploratory study. Benef Microbes. 2020;11:527\u201334.","journal-title":"Benef Microbes"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/s0004-2803.201700000-07","volume":"54","author":"F Martinello","year":"2017","unstructured":"Martinello F, Roman CF, Souza PAD. Effects of probiotic intake on intestinal bifidobacteria of celiac patients. Arq Gastroenterol. 2017;54:85\u201390.","journal-title":"Arq Gastroenterol"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1007\/s10620-015-3769-7","volume":"60","author":"M Klemenak","year":"2015","unstructured":"Klemenak M, Dolin\u0161ek J, Langerholc T, Di Gioia D, Mi\u010deti\u0107-Turk D. Administration of bifidobacterium breve decreases the production of TNF-\u03b1 in children with celiac disease. Dig Dis Sci. 2015;60:3386\u201392.","journal-title":"Dig Dis Sci"},{"key":"987_CR24","doi-asserted-by":"crossref","unstructured":"Ali B, Khan AR. Efficacy of probiotics in management of celiac disease. Cureus. 2022;14.","DOI":"10.7759\/cureus.22031"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fnut.2021.680771","volume":"8","author":"E Oscarsson","year":"2021","unstructured":"Oscarsson E, H\u00e5kansson \u00c5, Andr\u00e9n Aronsson C, Molin G, Agardh D. Effects of probiotic bacteria Lactobacillaceae on the gut microbiota in children with celiac disease autoimmunity: a placebo-controlled and randomized clinical trial. Front Nutr. 2021;8:354.","journal-title":"Front Nutr"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/nu11081925","volume":"11","author":"\u00c5 H\u00e5kansson","year":"2019","unstructured":"H\u00e5kansson \u00c5, Andr\u00e9n Aronsson C, Brundin C, Oscarsson E, Molin G, Agardh D. Effects of Lactobacillus plantarum and Lactobacillus paracasei on the peripheral immune response in children with celiac disease autoimmunity: a randomized, double-blind, placebo-controlled clinical trial. Nutrients. 2019;11:1925.","journal-title":"Nutrients"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5223\/pghn.2020.23.4.397","volume":"23","author":"K Demiroren","year":"2020","unstructured":"Demiroren K. Can a synbiotic supplementation contribute to decreasing anti-tissue transglutaminase levels in children with potential celiac disease? Pediatr Gastroenterol Hepatol Nutr. 2020;23:397.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"987_CR28","doi-asserted-by":"crossref","unstructured":"Aldaghi M-A, Dehghani S-M, Haghighat M. Evaluation of the correlation between tTG-IgA titer and duodenal biopsy findings in children with suspected celiac disease. Iran J Pediatr. 2016;26.","DOI":"10.5812\/ijp.3615"},{"key":"987_CR29","first-page":"415","volume":"38","author":"K Kingstone","year":"2001","unstructured":"Kingstone K, Gillett HR, Johnston SD, Smye M. Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease\/Author\u2019s reply. Ann Clin Biochem. 2001;38:415.","journal-title":"Ann Clin Biochem"},{"key":"987_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102375","author":"R Chibbar","year":"2019","unstructured":"Chibbar R, Dieleman LA. The gut microbiota in celiac disease and probiotics. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11102375.","journal-title":"Nutrients"},{"key":"987_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00430-017-0496-z","volume":"206","author":"A Girbovan","year":"2017","unstructured":"Girbovan A, Sur G, Samasca G, Lupan I. Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol. 2017;206:83\u201391. https:\/\/doi.org\/10.1007\/s00430-017-0496-z.","journal-title":"Med Microbiol Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00987-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:07:39Z","timestamp":1696079259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00987-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2320450\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-2320450\/v2","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by Ethic Committee of Alborz University of Medical Sciences, Karaj, Iran.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}]}}